Literature DB >> 14520695

Microsatellite instability in hereditary and sporadic breast cancers.

Camilo Adem1, Cheryl L Soderberg, Julie M Cunningham, Carol Reynolds, Thomas J Sebo, Stephen N Thibodeau, Lynn C Hartmann, Robert B Jenkins.   

Abstract

Sporadic cancers and familial breast cancers are characterized by an increase in genetic instability. Little is known about whether mismatch repair defects accompany this genetic instability. We investigated invasive and/or in situ breast cancers from 30 women with deleterious BRCA1/2 mutations and unclassified variant BRCA1/2 alterations. Forty cases of sporadic breast cancers were also investigated, including 7 medullary carcinomas. Malignant and benign lesions were examined from all cases to better understand tumor progression. Automated immunohistochemistry, with antibodies directed against hMLH1 and hMSH2, was used to screen cases for possible mismatch repair defects. When loss of expression was noted, DNA ploidy was performed by cytomorphometry. DNA, after laser microdissection, was extracted from a majority of familial cases and their corresponding controls, and microsatellite instability analysis was performed. None of the familial or sporadic cases had loss of hMSH2 expression. All but one lesion, a DCIS arising in a deleterious BRCA2 mutation carrier, had loss of hMLH1 expression and a tetraploid profile by image cytomorphometry. There was no MSI in any explored lesions (n = 34), as determined by molecular analysis, including the DCIS with loss of hMLH1 expression. We conclude that DNA mismatch repair defects involving hMLH1 and hMSH2 underexpression are extremely rare events in sporadic and familial breast cancer. Mismatch repair gene mutations may be secondary random events in breast cancer progression. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520695     DOI: 10.1002/ijc.11442

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Absence of microsatellite instability in mucinous carcinomas of the breast.

Authors:  Magali Lacroix-Triki; Maryou B Lambros; Felipe C Geyer; Paula H Suarez; Jorge S Reis-Filho; Britta Weigelt
Journal:  Int J Clin Exp Pathol       Date:  2010-11-27

Review 2.  Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.

Authors:  Valerie Lee; Adrian Murphy; Dung T Le; Luis A Diaz
Journal:  Oncologist       Date:  2016-07-13

3.  Anti-apoptotic proteins induce non-random genetic alterations that result in selecting breast cancer metastatic cells.

Authors:  Olga Méndez; Yolanda Fernández; Miguel A Peinado; Victor Moreno; Angels Sierra
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 4.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

5.  Microsatellite instability analysis of bilateral breast tumors suggests treatment-related origin of some contralateral malignancies.

Authors:  Ekatherina Sh Kuligina; Maxim Yu Grigoriev; Evgeny N Suspitsin; Konstantin G Buslov; Olga A Zaitseva; Olga S Yatsuk; Yulia R Lazareva; Alexandr V Togo; Evgeny N Imyanitov
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-10       Impact factor: 4.553

Review 6.  Phenotype-genotype correlation in familial breast cancer.

Authors:  Ana Cristina Vargas; Jorge S Reis-Filho; Sunil R Lakhani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-12       Impact factor: 2.673

Review 7.  Telomere shortening occurs early during breast tumorigenesis: a cause of chromosome destabilization underlying malignant transformation?

Authors:  Alan K Meeker; Pedram Argani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

8.  Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression.

Authors:  I Alldinger; K L Schaefer; D Goedde; L Ottaviano; U Dirksen; A Ranft; H Juergens; H E Gabbert; W T Knoefel; C Poremba
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-25       Impact factor: 4.553

9.  The Importance of Distinguishing Sporadic Cancers from Those Related to Cancer Predisposing Germline Mutations.

Authors:  Steven Sorscher
Journal:  Oncologist       Date:  2018-06-04

Review 10.  Checkpoint Inhibitors in the Treatment of Breast Cancer.

Authors:  Tomas G Lyons; Maura N Dickler; Elizabeth E Comen
Journal:  Curr Oncol Rep       Date:  2018-04-30       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.